Compare SIGA & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SIGA | WNEB |
|---|---|---|
| Founded | 1995 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.8M | 264.8M |
| IPO Year | 2016 | 2001 |
| Metric | SIGA | WNEB |
|---|---|---|
| Price | $3.16 | $13.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | ★ 649.1K | 44.9K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | ★ 13.24% | 2.00% |
| EPS Growth | N/A | ★ 33.93 |
| EPS | 0.13 | ★ 0.42 |
| Revenue | N/A | ★ $44,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $224.81 | $7.25 |
| P/E Ratio | ★ $23.46 | $32.86 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.83 | $10.78 |
| 52 Week High | $9.45 | $15.01 |
| Indicator | SIGA | WNEB |
|---|---|---|
| Relative Strength Index (RSI) | 51.99 | 49.26 |
| Support Level | $2.92 | $13.42 |
| Resistance Level | $3.32 | $14.17 |
| Average True Range (ATR) | 0.15 | 0.39 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 61.04 | 50.54 |
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.